Search research articles
Contact Us
Filters
Showing results (1-10 of 103) with videos related to
Page
of 11
Sort By:
Bulletin Du Cancer
|
February 22, 2001
[Cell therapy in solid tumors]
A Ravaud
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2007
New challenges in kidney cancer therapy: bevacizumab
A Ravaud
Asia-Pacific Journal of Clinical Oncology
|
August 28, 2020
Adjuvant therapy for high-risk renal cell carcinoma after nephrectomy how many trials are positive? Only one or more than one
A Ravaud
Presse Medicale (Paris, France : 1983)
|
October 14, 1989
[Not value to the systematic study of different tumor markers for disclosing bone metastasis]
A Ravaud
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 12, 2009
How to optimise treatment compliance in metastatic renal cell carcinoma with targeted agents
A Ravaud
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2013
Clinical biomarkers of response in advanced renal cell carcinoma
A Ravaud, M Schmidinger
The New England Journal of Medicine
|
May 1, 1999
Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state
L Capuron, A Ravaud
Critical Reviews in Oncology/Hematology
|
October 26, 1999
Present achievements in the medical treatment of metastatic renal cell carcinoma
A Ravaud, M Debled
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2009
Arterial hypertension and clinical benefit of sunitinib, sorafenib and bevacizumab in first and second-line treatment of metastatic renal cell cancer
A Ravaud, M Sire
Pathologie-Biologie
|
March 15, 2006
[Renal cell carcinoma: the end of a tunnel?]
A Ravaud, M-S Dilhuydy
Page
of 11
Search research articles
Search
Showing results (1-10 of 103) with videos related to
Sort By:
Page
of 11
Bulletin Du Cancer
|
February 22, 2001
[Cell therapy in solid tumors]
A Ravaud
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2007
New challenges in kidney cancer therapy: bevacizumab
A Ravaud
Asia-Pacific Journal of Clinical Oncology
|
August 28, 2020
Adjuvant therapy for high-risk renal cell carcinoma after nephrectomy how many trials are positive? Only one or more than one
A Ravaud
Presse Medicale (Paris, France : 1983)
|
October 14, 1989
[Not value to the systematic study of different tumor markers for disclosing bone metastasis]
A Ravaud
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 12, 2009
How to optimise treatment compliance in metastatic renal cell carcinoma with targeted agents
A Ravaud
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2013
Clinical biomarkers of response in advanced renal cell carcinoma
A Ravaud, M Schmidinger
The New England Journal of Medicine
|
May 1, 1999
Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state
L Capuron, A Ravaud
Critical Reviews in Oncology/Hematology
|
October 26, 1999
Present achievements in the medical treatment of metastatic renal cell carcinoma
A Ravaud, M Debled
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2009
Arterial hypertension and clinical benefit of sunitinib, sorafenib and bevacizumab in first and second-line treatment of metastatic renal cell cancer
A Ravaud, M Sire
Pathologie-Biologie
|
March 15, 2006
[Renal cell carcinoma: the end of a tunnel?]
A Ravaud, M-S Dilhuydy
Page
of 11